Novo Nordisk (NVO) faces a shareholder lawsuit over alleged securities fraud after the company cut its growth outlook
https://seekingalpha.com/news/4477652-novo-faces-shareholder-lawsuit-over-guidance-cut
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.